EP2023918A2

Cyclosporins for the treatment and prevention of ocular disorders

Abstract

Provided herein are methods for treatment of ocular diseases. The methods comprise administering a compound of general Formula (I): wherein R1, R2, R3, R4 and Ak are as defined in the specification.

Term

0.6 yearsto projected expiry

Projected expiry 18 May 2027, counted from filing; an application has no term until it is granted.

22 members in 12 offices

This recordMember, by publication date2 more offices are in the list below

Members22

Family members, oldest first
Document	Office	Kind
AU2007254148A1	Australia	A1	2007-11-29
CA2652662A1	Canada	A1	2007-11-29
WO2007136759A2	World Intellectual Property Organization (WIPO)	A2	2007-11-29
EP2023918A2This record	European Patent Office (EPO)	A2	2009-02-18
WO2007136759A3	World Intellectual Property Organization (WIPO)	A3	2009-04-16
CN101511357A	China	A	2009-08-19
JP2009537550A	Japan	A	2009-10-29
ZA200810113B	South Africa	B	2010-02-24
US2010062975A1	United States of America	A1	2010-03-11
EP2023918B1	European Patent Office (EPO)	B1	2011-03-23
AT502633T	Austria	T	2011-04-15
ATE502633T1	Austria	T1	2011-04-15
DK2023918T3	Denmark	T3	2011-04-26
DE602007013391D1	Germany	D1	2011-05-05
ES2361635T3	Spain	T3	2011-06-20
CN101511357B	China	B	2011-11-02
US8188052B2	United States of America	B2	2012-05-29
US2012270804A1	United States of America	A1	2012-10-25
AU2007254148B2	Australia	B2	2013-02-07
US8551952B2	United States of America	B2	2013-10-08
JP5377293B2	Japan	B2	2013-12-25
CA2652662C	Canada	C	2015-11-03

72 legal events, as 10 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2026-07-23	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-16	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-16	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-16	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-15	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-15	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-11	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-10	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-09	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-09	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-07-08	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-06-15	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2026-06-01	Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11	U11	CH
2025-07-18	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2018-05-28	Fee paymentPLFP	PLFP	FR
2017-05-29	Fee paymentPLFP	PLFP	FR
2016-12-15	Name/firm changedPFA	PFA	CH
2016-05-20	Fee paymentPLFP	PLFP	FR
2013-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2013-09-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2013-05-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2012-04-19	No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097	R097	DE
2012-02-29	No opposition filedOpposition26N	26N	EP
2012-02-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2012-01-27	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
2012-01-27	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
2011-12-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-12-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-08-25	Lt: invalidation of european patent or patent extensionLTIE	LTIE	EP
2011-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-07-29	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2011-07-26	Translation of granted ep patentGrantedTRGR	TRGR	SE
2011-06-20	Definitive protectionFG2A	FG2A	ES
2011-05-31	New agentNV	NV	CH
2011-05-05	Dpma publication of mentioned ep patent grantGrantedR096	R096	DE
2011-05-05	Corresponds to:REF	REF	EP
2011-04-26	Ep patent with danish claimsT3	T3	DK
2011-04-20	Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3	T3	NL
2011-04-13	European patents granted designating irelandGrantedFG4D	FG4D	IE
2011-03-31	European patent takes effect as a national patent in ch/liEP	EP	CH
2011-03-23	Designated contracting statesAK	AK	EP
2011-03-23	Request for extension of the european patentAX	AX	EP
2011-03-23	European patent grantedGrantedFG4D	FG4D	GB
2011-02-18	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2011-01-14	Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS	GRAS	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Information provided on ipc code assigned before grantRIC1	RIC1	EP
2010-09-15	Title (correction)CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF OCULAR DISORDERSRTI1	RTI1	EP
2010-08-13	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP	GRAP	EP
2009-08-19	First examination report despatched17Q	17Q	EP
2009-05-20	Deferred search report published (corrected)R17D	R17D	EP
2009-02-18	Request for examination filed17P	17P	EP
2009-02-18	Designated contracting statesAK	AK	EP
2009-02-18	Request for extension of the european patentAX	AX	EP
2009-01-16	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Cyclosporins for the treatment and prevention of ocular disorders

Abstract

Term

Members22

Over the term

Events

Numbers

Titles3

Classification

Designated states37